BIOLOGICAL · Unmapped registry intervention
anti-CD133-CAR vector-transduced T cells
Find medicine records ·
Find other trials using this name
Clinical trial
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
NCT02541370
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Liver Cancerverified · MONDO: liver cancer
Brain Tumorverified · MONDO: brain neoplasm
Breast Cancerverified · MONDO: breast cancer
Ovarian Tumorverified · MONDO: ovarian neoplasm
Colorectal Cancerverified · MONDO: colorectal cancer
Acute Myeloid and Lymphoid Leukemiasunresolved
Interventions
anti-CD133-CAR vector-transduced T cellsBIOLOGICAL
Sponsors & collaborators
Chinese PLA General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02541370 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.